Path Ex
TN - NashvilleBiotechnology
Focus: Path Ex is a Nashville-based biotechnology company developing extracorporeal blood cleansing devices for infectious diseases, specifically sepsis. The company is early-stage and publicly traded with a focused, single-asset pipeline.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Path Ex
AI assessmentNot HiringNo open roles listed right now. Follow Path Ex to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PATH EX CycloPE® Device
SepsisClinical Trials (1)
NCT06970899Initial Feasibility Study of the CycloPE® Device
N/AHelp build intelligence for Path Ex
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.